• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

IMS Health

How Virtual-First Clinical Trials Scale Access for Participants

by Rachael Scott, Chief Commercial Officer, Lightship 12/06/2022 Leave a Comment

How Virtual-First Clinical Trials Scale Access for Participants

Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.   Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More

Using AI to Match Patients with Clinical Trials for Proactive Treatment

by Lucas Glass, Vice President of the Analytics Center of Excellence, IQVIA 08/22/2022 Leave a Comment

Lucas Glass, Vice President of the Analytics Center of Excellence, IQVIA

We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More

Ensuring A Healthy Approach to Big Data In The Life Sciences Industry

by Ferdi Steinmann, Industry Strategist for Life Sciences, OpenText 09/17/2019 Leave a Comment

Ensuring a Healthy Approach to Big Data in the Life Sciences Industry

The old adage “knowledge is power” may seem cliched, but it definitely still rings true in the life sciences industry. In fact, maybe more so than in any other industry, healthcare insights are being driven by a vast array of critically important data from scientific research, clinical trials, and patient profiling. Teams are continually asked to identify, prioritize and develop promising therapies which are not only safe but innovative, effective and based on the latest research. To achieve
Read More

Verana Health Lands $30M for EHR Integrated Data Platform for Life Sciences

by Fred Pennic 07/31/2018 Leave a Comment

Verana Health Lands $30M for EHR Integrated Data Platform for Life Sciences

Verana Health formerly known as DigiSight Technologies), a healthcare technology developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets has raised $30M in Series C funding led by  GV (formerly Google Ventures) with participation from existing investors Biomatics Capital, Brook Byers, founder of Kleiner, Perkins, Caufield & Byers, GE Ventures, and Lagunita Biosciences.In addition to the Series C funding, the company has appointed
Read More

TPG Capital to Acquire Mediware Information Systems for Undisclosed Sum

by Jasmine Pennic 12/21/2016 Leave a Comment

TPG Capital, the global private equity fund of leading alternative asset firm TPG has entered an agreement to acquire Mediware Information Systems, Inc. from private equity firm Thoma Bravo. Financial terms of the acquisition were not disclosed. The acquisition is expected to close during the first quarter of 2017, subject to customary closing conditions.For more than 30 years, Mediware has been a leading supplier of healthcare and human service software for the nation’s largest blood banks,
Read More

IMS Health Acquires Canada-based Privacy Analytics

by Fred Pennic 05/27/2016 Leave a Comment

IMS Health Acquires Canada-based Privacy Analytics

IMS Health has acquired Canada-based Privacy Analytics, a technology provider that enables healthcare organizations to unleash the value of sensitive data for secondary purposes without compromising personal health information. The acquisition will help IMS Health strengthen its robust Real-World Evidence (RWE) capabilities and advance the company’s ability to help life sciences clients drive R&D and commercial performance and demonstrate treatment value in real-world settings. MS Health
Read More

IMS Health, Quintiles to Merge in $9B Deal: 10 Things To Know

by HITC Staff 05/04/2016 Leave a Comment

IMS Health, Quintiles to Merge in $9B Deal: 10 Things To Know

Healthcare technology provider IMS Health Holdings announced it will merge with biopharma research contract provider Quintiles Transnational Holding in a deal valued at $9 billion. The merged company will be named Quintiles IMS Holdings, Inc. to become an industry-leading information and technology-enabled healthcare service provider. Here are ten key things to know about the $9B merger: 1.Based on equity market capitalization, the combined company is valued at more than $17.6 billion with an
Read More

5 Required Competencies of A Successful Life Sciences CIO

by Jasmine Pennic 02/04/2016 Leave a Comment

IMS Health

More than 80 percent of leading life sciences companies have created new digital and innovation leadership roles to capitalize on the information technology transformation in healthcare, with nearly half hiring new chief information officers during the past three years, according to new research issued this week by the IMS Institute for Healthcare Informatics. The rise of mobile, cloud, predictive analytics and other digital innovations offers new opportunities for advancing patient care as
Read More

Total Dollars Spent on Medications in the U.S. Reached $329.2B in 2013

by Fred Pennic 04/15/2014 Leave a Comment

Revenue Cycle M&A Deals_Total Dollars Spent on Medications in the U.S. Reached $329.2B in 2013

The total dollars spent on medications in the U.S. reached $329.2 billion in 2013, up 3.2 percent, according to according to a new report issued today by the IMS Institute for Healthcare Informatics.
Read More

The Velocity of Big: IMS Health Launches with Plans to Industrialize mHealth

by Lois Drapin 12/20/2013 1 Comment

The Velocity of Big: IMS Health launches with Plans to Industrialize mHealth

Lois Drapin provides her post 2013 mHealth Summit insights on how IMS Health plans to move mHealth into a more industrialized environment for mhealth apps.
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |